ProteoTech's Chief Scientific Officer, Dr. Alan Snow, to Present New Data on "SystebrylTM for the Treatment of Systemic AA Amyloidosis" at the XIIIth International Symposium on Amyloidosis, Groningen, Netherlands, May 6-10, 2012

KIRKLAND, Wash.--(BUSINESS WIRE)--ProteoTech Inc. announced that the Company's President & Chief Scientific Officer, Alan D. Snow, Ph.D., will give an oral presentation on Thursday, May 10, 2012 at the XIII International Symposium on Amyloidosis, University Medical Center, Groningen, Netherlands. The title of Dr. Snow's presentation is: "Marked Removal and Clearance of AA Amyloid Deposits in Target Organs (Kidney, Liver and Spleen) by the Small Molecule SystebrylTM Following Oral Administration: A Potential Break-through Drug for the Treatment of Systemic AA Amyloidosis."